Default: Hematology/Oncology and Stem Cell Therapy

ISSN: 1658-3876

Journal Home

Journal Guideline

Hematology/Oncology and Stem Cell Therapy Q2 Unclaimed

King Faisal Specialist Hospital and Research Centre Saudi Arabia
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Hematology/Oncology and Stem Cell Therapy is a journal indexed in SJR in Medicine (miscellaneous) and Hematology with an H index of 30. It is an CC BY-NC-ND Journal with a Double blind peer review review system The scope of the journal is focused on haematology, oncology, hematopoietic stem cell therapy. It has an SJR impact factor of 0,601 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,601.

Type: Journal

Type of Copyright: CC BY-NC-ND

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Hematology/Oncology and Stem Cell Therapy

0,601

SJR Impact factor

30

H Index

59

Total Docs (Last Year)

141

Total Docs (3 years)

851

Total Refs

248

Total Cites (3 years)

138

Citable Docs (3 years)

1.58

Cites/Doc (2 years)

14.42

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


Haematology Oncology Hematopoietic stem cell therapy



Best articles by citations

Primary CNS lymphoplasmacytic lymphoma: A case report and review of literature

View more

Current concepts on hematopoietic stem cell transplantation outcome registries; Emphases on resource requirements for new registries

View more

Blastic plasmacytoid dendritic cell neoplasm: A rare subtype of myeloid leukemia

View more

Yield of computed tomography pulmonary angiogram in the emergency department in cancer patients suspected to have pulmonary embolism

View more

Microgranular acute promyelocytic leukemia presenting with leukopenia and an unusual immunophenotype

View more

Early T cell precursor lymphoid blast crisis of chronic myeloid leukemia -A novel transformation

View more

Successful treatment of hydroxyurea-associated chronic leg ulcers associated with squamous cell carcinoma

View more

Durable remission of a patient with primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma

View more

Intraocular involvement of Mantle cell lymphoma: A case report and literature review

View more

Metronomic capecitabine as extended adjuvant chemotherapy in women with triple negative breast cancer

View more

THPO-MPL pathway and bone marrow failure

View more

Wilms tumor: Successes and challenges in management outside of cooperative clinical trials

View more
SHOW MORE ARTICLES

Impact of RB1 gene mutation type in retinoblastoma patients on clinical presentation and management outcome

View more

WITHDRAWN: Updates in Prognostication and Treatment of Waldenstrom's Macroglobulinemia

View more

Detection of del(16q) using the CBFB-MYH11 translocation dual fusion probe

View more

Monocyte derived dendritic cells have reduced expression of co-stimulatory molecules but are able to stimulate autologous T-cells in patients with MDS

View more

Outcomes of high-risk acute promyelocytic leukemia patients treated with arsenic trioxide (ATO)/all trans retinoic acid (ATRA) based induction and consolidation without maintenance phase: A case Series

View more

Orbital myeloid sarcoma presenting as massive proptosis

View more

Dengue fever as a cause of febrile neutropenia in adult acute lymphoblastic leukemia: A single center experience

View more

Dengue fever causing febrile neutropenia in children with acute lymphoblastic leukemia: An unknown entity

View more

Acute promyelocytic leukemia in a patient with chronic lymphocytic leukemia - A case report

View more

Impact of vitamin D deficiency on increased blood eosinophil counts

View more

Faggot cells in a non-promyelocytic acute myeloid leukemia

View more

Could the mosaic pattern of chromosomal abnormality predict overall survival of patients with myelodysplastic syndrome?

View more

FAQS